New diabetes clinical trial: Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Published on: 2026-09-04T04:00:00Z Conditions : Overweight , Obesity; Type 2 Diabetes Mellitus (T2DM); MASH - Metabolic Dysfunction-Associated Steatohepatitis Interventions : Drug: MWN105 1; Drug: MWN105 2; Drug: MWN105 3; Drug: Placebo Sponsors : Shanghai Minwei Biotechnology Co., Ltd Recruiting https://ift.tt/cVNS6wi